JZMed Inc., Jan 2011, Pages: 282
as an acceptable destination for genomics- and proteomics-related research.
The report, “Outlook of China Genomics and Proteomics Market – Application in Molecular Biomarker, Diagnostics and Personalized Medicine
ICON Group International, Jan 2011, Pages: 142
smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for moleculardiagnostics in Greater China is not actual
ICON Group International, Dec 2008, Pages: 141
smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for moleculardiagnostics in Greater China is not actual
Global Industry Analysts, Inc., Oct 2010, Pages: 659
This report analyzes the worldwide markets for MolecularDiagnostics in US$ million by the following segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening.
The report
Koncept Analytics, June 2011, Pages: 43
Moleculardiagnostics refers to the technique of identifying the presence of any infection or disease, gene mutations, or any type of antigens attacking the body, with the help of the genetic
AMID Co., Jan 2010, Pages: 182
China's demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China
Bizacumen Inc., Nov 2009, Pages: 249
in DNA array technologies are major growth facilitators for the DNA probes-based diagnostic products market.
In the area of molecular in-vitro diagnostics, DNA based diagnostics represent the most
Frost & Sullivan, July 2010, Pages: 122
, technologies, drivers and restraints, competitive structure, and company market shares. It covers the immunochemistry, microbiology, point-of-care, moleculardiagnostics, hemostasis, hematology, self monitoring
RNCOS E-Services Private Limited, Dec 2011, Pages: 130
tremendous growth in the recent years. The developments in the point-of-care and moleculardiagnostics segment are also found to be high. The research also observes that the increasing prevalence of chronic
Renub Research, Sep 2010, Pages: 89
market. The report provides market landscape, competitive landscape and market trends information on ten market categories including MolecularDiagnostics, Clinical Chemistry, Hematology, Immunoassay, Point of Care
Global Industry Analysts, Inc., Feb 2011, Pages: 477
Acquires Cholestech 76
Acrongenomics, Pearson and Molecular Enter into Joint Venture 77
Cholestech Teams Up with Onsite Health Diagnostics 77
Lipomics to Collaborate with Agilent Technologies to Develop
Decision Resources, Inc., April 2009, Pages: 29
One of the fastest-growing segments of moleculardiagnostics is nucleic acid testing (NAT). NAT is central to the life sciences industry, to improved healthcare, and to personalized medicine. Tools
Markets and Markets, April 2010, Pages: 155
the BRIC IVD market on the basis of:
- Geography: Brazil, Russia, India and China
- Diagnostic Services: Hematology, immunology, microbiology, moleculardiagnostics, urine analysis, etc.
Each section
Global Industry Analysts, Inc., Aug 2011, Pages: 239
technological advancements in Fluorescence In Situ Hybridization as well as array-based technology have taken Cytogenetics to an entirely new level in the areas of research and moleculardiagnostics. Molecular
Dion Global Solutions Ltd., Oct 2010, Pages: 15
the past few years. As per our new research on the sector “Asia Pacific In Vitro Diagnostic Market Analysis: China Market Perspective”, the IVD market in China is estimated to grow at a CAGR of over 14.5 per
China Research & Intelligence, April 2009, Pages: 60
necessary diagnostics reagents were self-prepared by the technicians. In the 1970s, China began to introduce some foreign advanced equipments and technologies. Since the 1980s, Chinese clinical diagnostic
Business Insights, March 2009, Pages: 160
The in-vitro diagnostics (IVD) market continues to grow at a steady pace, driven by new fields such as moleculardiagnostics and a growing consumer awareness surrounding disease management